Abstract
Objectives Therapeutic, regulatory and technological changes have contributed to new directions in abortion care. We aimed to gather views of healthcare professionals on current and future regulation and provision of abortion in Britain.
Design Cross sectional, stratified cluster sample survey with additional free text comments.
Setting Healthcare settings in Britain
Participants Healthcare professionals (nurses, doctors, midwives, pharmacists) working in a range of healthcare services, including dedicated abortion services.
Measures Knowledge of and attitudes towards the regulation and provision of abortion.
Results 771 healthcare professionals from all areas of Britain responded to the survey. Support for abortion being a woman’s choice was high, more than nine in ten saw it as such and a clear majority favoured abortion being treated as a health rather than a legal issue. Only 6.2% saw abortion at any gestational age as contrary to their personal beliefs and a similarly small minority (6.7%) were against abortion after 12 weeks gestation. One in five of all healthcare professionals and a third of those aged under 30 were unaware that the law in Britain requires two doctors to authorise an abortion. Free text comments revealed opposition to the need for this legal requirement. Support for an extended role for nurses in abortion care was high; two thirds (65.3%) agreed that nurses should be able to prescribe abortion medication. Little more than a third of all healthcare professionals (37%) agreed that abortion should be standard practice in their service; the proportion was highest among those in sexual and reproductive health services (58.4%) and lowest among those in general practice (18.7%).
Conclusions Health care professionals in Britain are generally supportive of abortion being treated in the same way as other health issues and would be likely to support any moves to decriminalise abortion.
Strengths and limitations of the study
Strengths and limitations of the study
The study describes the views of a range of healthcare professionals in different specialities and settings on the current and future regulation and provision of abortion.
The use of a stratified cluster sampling strategy increases the generalisability of findings.
Additional qualitative data from free text comments helps in understanding the survey responses.
The main limitation stems from the timing of the study. Scheduling fieldwork at the height of the COVID-19 pandemic and its immediate aftermath may have introduced both participation and reporting bias.
Healthcare professionals most actively involved in coping with the pandemic may have declined to participate because of time pressures and/or provided responses influenced by awareness of the current constraints of their workload.
What is already known on this topic
What is already known on this topic
The 21st century has seen major changes in the landscape of abortion. Therapeutic and technological advances have led to an increase in the prevalence of medication abortion which can be safely managed by women at home and have provided the innovative telemedical interventions enabling them to do so.
The trends have prompted reflection on the appropriate regulation of abortion in Britain, on the role of different cadres of healthcare professionals; and on the appropriate healthcare settings in which abortion can be provided. Little is known about the views of health care professionals on these issues.
What this study adds
What this study adds
The law on abortion is not widely known. One in five of all health care professionals and one in three aged under 30 are not aware that for abortion to be legal in Britain two doctors must certify that certain grounds have been met.
There is near universal support among healthcare professionals for abortion being a woman’s choice and a widely held view that abortion should be treated no differently from any other health condition.
Enthusiasm for incorporating abortion into existing practice is high among healthcare professionals employed in sexual and reproductive health services but most of those in general practice see abortion provision as out of scope for their service.
An extended role in abortion for nurses commands considerable support among healthcare professionals, including prescribing abortion medication and, whilst the legal requirement to do so remains, to authorise abortions.
How this study might affect research, practice or policy
How this study might affect research, practice or policy
Should there be political will in Britain for a legal reform that removes specific criminal prohibitions against abortion, our data suggest that it would encounter strong support amongst healthcare professionals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Ethical approval was obtained from the Research Ethics Committees of the London School of Hygiene & Tropical Medicine (Refs. 22761/26332) and the National Health Service (NHS) (Ref. 21/LO/0236)/ NHS Health Research Authority (IRAS Approval ID 297849).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval was obtained from the Research Ethics Committees of the London School of Hygiene & Tropical Medicine (Refs. 22761/26332) and the National Health Service (NHS) (Ref. 21/LO/0236)/ NHS Health Research Authority (IRAS Approval ID 297849).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
(and the SACHA study team #)
1 https://www.lshtm.ac.uk/research/centres-projects-groups/sacha
Data Availability
All data publicly available from the study are contained in the manuscript
